Shanghai provider of personalized tumor treatment services, including molecular diagnosis and pathology testing.
Founded in 2010 and based in Shanghai, China, Shanghai Sai'an Biomedical Technology Co., Ltd. is a personalized tumor treatment service provider. Its work spans scientific research, product development and clinical services in biomedicine, including molecular diagnosis for personalized tumor treatment and pathological diagnosis of difficult tumors. Revenue comes from clinical testing services. In January 2016 it closed Series B funding from new investors Ysun Investment and Galaxy Biomedical Investment.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in